Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone
نویسندگان
چکیده
PG: pyoderma gangrenosum TNF: tumor necrosis factor INTRODUCTION Pyoderma gangrenosum (PG) is a neutrophilic dermatosis with an important inflammatory component that usually presents as a nonhealing ulcer. This cutaneous disorder has been associated with several systemic conditions including inflammatory bowel disease. Treatment options for PG in pregnancy are limited. We present a case of pyoderma gangrenosum in a gravid patient treated successfully with infliximab and prednisone.
منابع مشابه
Case of Pyoderma Gangrenosum Associated with Ulcerative Colitis Successfully Treated with Infliximab
Pyoderma gangrenosum (PG) is a rare, ulcerating inflammatory skin disease. PG is often associated with systemic diseases, including inflammatory bowel disease (IBD). Herein, we report a case of PG associated with ulcerative colitis successfully treated with infliximab. Our case report supports the efficacy of infliximab for refractory case of PG with IBD.
متن کاملIntroducing a Case of Pyoderma Gangrenosum in the Breast
Introduction: Pyoderma gangrenosum (PG) of the breast is a rare that present as a painful ulcer on the skin. It usually affects people in their 20s to 50s and occurs in both men and women. Typically, PG affects the legs in adults. In children, it may affect the legs, buttocks, head, and neck. Pyoderma gangrenosum is characterized by a papule, nodule, or pustule that progresses to an injured les...
متن کامل[Perineal pyoderma gangrenosum in a girl treated with adalimumab after infliximab failure].
Pyoderma gangrenosum (PG) is an ulcerative cutaneous condition of unknown etiology (1). It was first described in 1930 (2) and it is associated with systemic diseases as inflammatory bowel disease (IBD). We present the case of a girl with a perineal PG who after failure of infliximab was successfully treated with adalimumab. The most common extraintestinal disorders related with inflammatory bo...
متن کاملUse of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
Pyoderma gangrenosum (PG) is characterized by ulcerative skin lesions. Infliximab (IFX) may promote PG healing in patients with inflammatory bowel disease, but whether IFX is effective for treating PG in patients with rheumatoid arthritis (RA) has not reported. We report the case of a 53-year-old woman with PG complicated by RA who was treated using IFX therapy. This case suggests that IFX ther...
متن کاملMycophenolate mofetil as therapy for pyoderma gangrenosum.
BACKGROUND Pyoderma gangrenosum is an ulcerative condition that may be associated with inflammatory bowel disease or inflammatory arthritis. In addition to local wound care, management often includes the use of systemic corticosteroids or systemically administered immunomodulatory agents. OBSERVATIONS We retrospectively analyzed 7 patients with pyoderma gangrenosum who were treated with mycop...
متن کامل